Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World Settings
- Status
- COMPLETED
- Phase
- N/A
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
- Status
- COMPLETED
- Phase
- N/A
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Status
- COMPLETED
- Phase
- N/A
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2